Tuberculosis is the leading cause of death from an infectious disease. The world can end the epidemic, but only if the best tests and medicines are brought to everybody who needs them.
We are investing US$ 215 million in new drugs, diagnostics and models of care to deal with TB in all its forms, especially in high-risk populations such as children and people living with HIV, and our TB funding is on track to hit US$ 300 million in 2020.
On the occasion of World TB Day 2019, click on the links below to see how our catalytic investments are changing the way the world is fighting the epidemic:
Unitaid’s work in TB:
Watch our short films and animations: